跳至主要内容
临床试验/NCT07022548
NCT07022548已完成不适用

Prospective Study Evaluating the Prevalence of Intestinal Dysfunction in Hematology Patients Hospitalized in Intensive Care for Sepsis or Septic Shock

University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年11月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Prevalence of intestinal inflammation

研究概览

简要总结

The intestinal tract has multiple functions within the body beyond its primary function of nutrient absorption. It acts as a true barrier protecting the body from living microorganisms and antigens in the intestinal lumen. Impairment of any component of the intestinal barrier results in nutrient malabsorption, an altered local digestive immune response, and increased intestinal permeability.

The primary function of this barrier is to limit the access of the contents of the intestinal lumen, which particularly includes the bacterial components of the microbiota, to the internal environment and the circulation. This physical barrier function is provided by a monolayer of epithelial cells, closely connected to each other by intercellular junctions (tight junctions, adherens and desmosomes, as well as by the mucus which covers the apical surface of the cells, the constituents of which, mucins, are secreted by the goblet cells. The term intestinal barrier is also used in a broader sense including a protective role against the invasion of environmental pathogens, while allowing toleranSepsis-associated intestinal failure is often underestimated, yet it is found in 20 to 60% of ICU (Intensive Care Unit)vpatients. However, its prognosis is poorly documented. For example, there is no consensus definition of this dysfunction or validated biomarkers for rapid assessment. Consequently, it does not appear in most prognostic scores (SOFA, IGS2, etc.).

Intestinal permeability, a risk factor for bacterial translocation when elevated, is increased in ICU (Intensive Care Unit) patients and associated with multiorgan failure system (MODS), particularly in cases of intestinal fasting. However, there is currently no validated marker of acute intestinal failure in intensive care or intensive care.ce towards commensal flora and foods.

详细描述

Several markers of intestinal response have been studied and are still in the research field due to a lack of conclusive work on their impact.

Clinically, both in post-weaning children and in adults, citrullinemia (citrulline deficiency) is well established as a sensitive and specific indicator of functional absorptive enterocyte mass.

Fecal calprotectin is already used as a marker of neutrophil-mediated inflammation in inflammatory bowel disease.

A recent controlled observational study of 165 patients investigated serum calprotectin as a prognostic marker in sepsis patients hospitalized in critical care. The authors found a significant increase in serum calprotectin concentration in sepsis patients compared to control patients. Furthermore, it would appear that a high level of calprotectin upon admission to intensive care is a significant risk factor for long-term mortality.

Finally, in patients with sepsis, serum zonulin levels are elevated, which promotes bacterial translocation via the epithelium and thus bacteremia.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Population with hematologic malignancy
  • •Patients over 18 years of age
  • •Suffering from hematologic malignancy
  • •Admitted to intensive care for sepsis or septic shock according to sepsis definition 3:
  • •Sepsis: organ dysfunction (SOFA > or = 2) related to a host response to infection
  • •Septic shock: sepsis with acute circulatory failure and metabolic abnormalities (serum lactate > 2 mmol/L) and vasopressors
  • •Patients who have read and understood the information letter and do not object to participating in the study
  • •Affiliated with or beneficiary of a social security scheme.
  • •Control population
  • •- Patient aged over 18
  • •Admitted to intensive care for sepsis or septic shock according to the sepsis definition 3:
  • •Sepsis: organ dysfunction (SOFA > or = 2) related to a host response to infection
  • •Septic shock: sepsis with acute circulatory failure and metabolic abnormalities (serum lactate > 2 mmol/L) and vasopressors
  • •Patient who has read and understood the information letter and does not object to participating in the study
  • •Member of or beneficiary of a social security scheme

排除标准

  • •For the control group and those with hematologic malignancies:
  • •Patient refusal
  • •Pregnant, parturient, or breastfeeding woman
  • •Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
  • •Person who does not understand or speak French
  • •Limitations of active therapies (LATA) established upon admission
  • •Hospitalization in intensive care > 72 hours

结局指标

主要结局

Prevalence of intestinal inflammation

时间窗: 72 hours after enrollment visit

To assess the prevalence of intestinal inflammation defined by the fecal calprotectin level on admission (\<72 hours) in patients with malignant hematological disease admitted to intensive care for sepsis or septic shock.

次要结局

  • Impact of intestinal dysfunction on mortality(month 6)
  • Prevalence of intestinal hyperpermeability(72 hours after enrollment visit)
  • Integrity of intestinal tissue(72 hours after enrollment visit)
  • Impact of intestinal dysfunction on the occurrence of digestive intolerance(month 6)

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验